MENU
+Compare
RLMD
Stock ticker: NASDAQ
AS OF
Feb 4, 04:59 PM (EDT)
Price
$0.34
Change
-$0.00 (-0.00%)
Capitalization
10.26M

RLMD Relmada Therapeutics Chart, History Price & Graph

a clinical-stage biotechnology company, which engages in the development of d-methadone receptor antagonist, which is a chemical entity that addresses areas of high unmet medical need in the treatment of central nervous system diseases

Industry Biotechnology
RLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
View a ticker or compare two or three
RLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...

RLMD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RLMD has been loosely correlated with SYRE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if RLMD jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLMD
1D Price
Change %
RLMD100%
+0.06%
SYRE - RLMD
36%
Loosely correlated
+3.49%
ENTO - RLMD
36%
Loosely correlated
-5.23%
ALVR - RLMD
35%
Loosely correlated
+2.65%
SCPX - RLMD
34%
Loosely correlated
-4.16%
PRTC - RLMD
31%
Poorly correlated
-0.77%
More